RNS Number : 9227V
Bowleven plc
06 December 2023

6 December 2023

Bowleven plc

('Bowleven' or 'The Company')

RESULT OF Annual General Meeting

Bowleven held its Annual General Meeting (the 'AGM') earlier today. Each resolution put to the AGM is set out in full in the Notice of AGM. Each shareholder present in person or by proxy was entitled to one vote per share held.

Resolutions numbered 1 to 6, all of which were proposed as ordinary resolutions, were passed. Resolutions 7 and 8 relating to the disapplication of statutory pre-emption rights, which were proposed as special resolutions, did not achieve the 75% of votes and therefore were not passed. The Board will seek to consult with certain shareholders as to why they voted against these resolutions. Details of the voting in respect of each resolution are outlined in the table below.

Total number of votes

RESOLUTION

FOR1

%

AGAINST

%

Resolution 1 (Ordinary)

Report and Accounts

6,460,380

76.07

2,032,394

23.93

Resolution 2 (Ordinary)

Re-appoint GT

6,437,623

75.80

2,055,151

24.20

Resolution 3 (Ordinary)

Determine auditor's renumeration

8,360,172

99.60

33,573

0.40

Resolution 4 (Ordinary)

Re-elect Eli Chahin

8,130,835

96.89

261,047

3.11

Resolution 5 (Ordinary)

Re-elect Jack Arnoff

8,130,646

96.89

261,236

3.11

Resolution 6 (Ordinary)

Allot Shares

8,093,735

96.07

331,143

3.93

Resolution 7 (Special)

Pre-emption Rights

6,089,172

73.03

2,249,093

26.97

Resolution 8 (Special)

Pre-emption Rights 2

6,089,172

72.51

2,309,093

27.49

1 Includes votes giving discretion to the Chairman

Note: the table above excludes votes withheld

ENQUIRIES


For further information, please contact:




Bowleven plc


Eli Chahin, Chief Executive

00 44 20 3327 0150


Capital Markets Communications Ltd (Camarco)


Owen Roberts

Hugo Liddy

00 44 20 3757 4980



Shore Capital Ltd (NOMAD and Broker)


Robert Finlay

00 44 20 7601 6100

Daniel Bush

Angus Murphy


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RAGFLFSEFFLRIIV